¼¼°èÀÇ Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ ½ÃÀå : ¼ººÐº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Submucosal Lifting Agent Market, By Ingredient, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1555743
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 322 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,702,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,728,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,174,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 1¾ï 1, 590¸¸ ´Þ·¯·Î 2024³âºÎÅÍ 2032³â±îÁö º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 7.20%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.

Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ ½ÃÀå : ½ÃÀå ¿ªÇÐ

Æú¸³, ¼±Á¾, Á¶±â¾Ï µî ¼ÒÈ­±â ÁúȯÀÇ À¯º´·ü »ó½ÂÇÒ Àü¸ÁÀÔ´Ï´Ù.

¼ÒÈ­±â ÁúȯÀÇ ¹ß»ý·ü Áõ°¡´Â Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, Àü±¸ Áõ»óÀ¸·Î Æú¸³°ú ¼±Á¾À» µ¿¹ÝÇÏ´Â °æ¿ì°¡ ¸¹Àº ´ëÀå¾ÏÀº ¼¼°èÀûÀ¸·Î °¡Àå ÈçÇÑ ¾Ï Áß ÇϳªÀ̸ç, 2020³â¿¡¸¸ 190¸¸¸í ÀÌ»óÀÇ ½Å±Ô Áõ·Ê°¡ º¸°íµÇ¾ú½À´Ï´Ù. Ä¡·áÇÏÁö ¾ÊÀ¸¸é ¾ÏÀ¸·Î ÁøÇàµÉ °¡´É¼ºÀÌ ÀÖ´Â ¼±Á¾¼º Æú¸³ÀÇ À¯º´·üÀº ÇöÀúÇϰí, 50¼¼ ÀÌ»óÀÇ ¼ºÀÎÀÇ ÃÖ´ë 30%°¡ ÀÌ·¯ÇÑ Æú¸³À» °¡Áö°í ÀÖÀ» °¡´É¼ºÀÌ ÀÖ´Ù´Â Á¶»ç °á°úµµ ÀÖ½À´Ï´Ù. Áø´Ü ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó ³»½Ã°æÀû Á¡¸·ÀýÁ¦¼ú(EMR) ¹× ³»½Ã°æ Á¡¸· ÇÏÃþ ¹Ú¸®¼ú(ESD)°ú °°Àº È¿°úÀûÀÎ Á¡¸· ÇÏÃþ ¹Ú¸®Á¦¿¡ ÀÇÁ¸ÇÏ´Â Á¤¹Ð ³»½Ã°æ ±â¼úÀÇ Çʿ伺 °¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¾àÀº Á¡¸·°ú ±× ¾Æ·¡ Á¶Á÷ »çÀÌ¿¡ Äí¼ÇÀ» ¸¸µå´Â µ¥ µµ¿òÀÌ µÇ¸ç, º´º¯À» ¾ÈÀüÇϰí È¿°úÀûÀ¸·Î ÀýÁ¦Çϰí Ä¡·áÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» Çâ»ó½ÃÄÑ ÀÌ·¯ÇÑ Á¦Ç° ½ÃÀå È®´ë¸¦ Áö¿øÇÕ´Ï´Ù.

Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ ½ÃÀå : ÁÖ¿ä ÀλçÀÌÆ®·Â

¿ì¸®ÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È¿¡ ¾à 7.20%ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼ººÐ ¼¼ºÐÈ­¿¡ ±âÃÊÇÏ¿©, È÷¾Ë·ç·Ð»ê ³ªÆ®·ýÀº 2023³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» º¸¿©ÁÙ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿ëµµº°·Î´Â 2023³â¿¡´Â Æú¸³ÀÌ ÁÖ¿ä À¯ÇüÀ¸·Î

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ¼öÀÍÀ¸·Î À̲ø¾ú½À´Ï´Ù.

Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ ½ÃÀå :¼¼±×¸ÕÅ×ÀÌ¼Ç ºÐ¼® :

¼¼°èÀÇ Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ ½ÃÀåÀº ¼ººÐ, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº ¼ººÐ¿¡ ±âÃÊÇÏ¿© 6°³ÀÇ Ä«Å×°í¸®·Î ³ª´µ¾îÁø´Ù: È÷¾Ë·ç·Ð»ê ³ªÆ®·ýÀº ¾ÈÁ¤ÇÑ Á¡¸·ÇÏ ¸®ÇÁÆÃÀ» Á¦°øÇϴ Ź¿ùÇÑ ´É·Â¿¡ ÀÇÇØ ÀÌ Å¬·¡½º¿¡¼­ °¡Àå À¯¸íÇÑ ¼ººÐÀ¸·Î °£ÁֵǴ °æ¿ì°¡ ¸¹½À´Ï´Ù. ±×°ÍÀÇ È¿´ÉÀº ÀÓ»ó ÇöÀå¿¡¼­ Àß ÀÔÁõµÇ¾ú°í Á¡¸· ¸®ÇÁÆÃÀÇ ¿ì¼öÇÑ ¼º´ÉÀ¸·Î ³Î¸® »ç¿ëµË´Ï´Ù. ¶ÇÇÑ, È÷¾Ë·ç·Ð»ê³ªÆ®·ýÀº Ź¿ùÇÑ »ýüÀûÇÕ¼ºÀ» ÅëÇØ ü³» Á¶Á÷°úÀÇ ¿øÈ°ÇÑ ÅëÇÕÀ» º¸ÀåÇϰí, °­ÇÑ ¾ÈÀü¼º ÇÁ·ÎÆÄÀÏÀ» ÅëÇØ ºÎÀÛ¿ëÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­ÇÒ ¼ö Àֱ⠶§¹®¿¡ ³ôÀº Æò°¡¸¦ ¹Þ¾Ò½À´Ï´Ù. ÀÌ È¿°ú, ÀûÇÕ¼º ¹× ¾ÈÀüÀÇ Á¶ÇÕÀº ´Ù¾çÇÑ ÀÇ·á ¹× ¹Ì¿ë ÀÀ¿ë ºÐ¾ß¿¡¼­ ¼±È£ÇÏ°í »ç¿ëµË´Ï´Ù.

½ÃÀåÀº ¿ëµµº°·Î 5°¡Áö ¹üÁÖ·Î ºÐ·ùµË´Ï´Ù. À̴ ƯÈ÷ ³»½Ã°æÀû Á¡¸·ÀýÁ¦¼ú(EMR)À̳ª ³»½Ã°æÀû Á¡¸·ÇÏÃþ¹Ú¸®¼ú(ESD)°ú °°Àº Æú¸³ÀÇ ÀýÁ¦ ¹× Ä¡·á¿¡ À־ Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÀÌ ÀϹÝÀûÀ¸·Î ä¿ëµÇ±â ¶§¹®ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀýÂ÷´Â Æú¸³ ¹× ±âŸ º´º¯ÀÇ Á¤È®ÇÑ Á¦°Å¸¦ ¿ëÀÌÇÏ°Ô Çϱâ À§ÇØ Á¡¸·ÃþÀ» È¿°úÀûÀ¸·Î µé¾î¿Ã¸®´Â °Í¿¡ ÀÇÁ¸Çϸç, Æú¸³Àº ÀÌ ºÐ¾ß¿¡¼­ Áß¿äÇÑ ÃÊÁ¡ÀÌ µÇ°í ÀÖ½À´Ï´Ù.

Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ ½ÃÀå : Áö¸®Àû ÀλçÀÌÆ®

ºÏ¹ÌÀÇ Á¡¸· ÇÏÃþ ¸®ÇÁÆÃ ½ÃÀåÀº ³·Àº ħ½À ¼ö¼ú¿¡ ´ëÇÑ °­ÇÑ ¼ö¿ä¿Í ±Þ¼ÓÇÑ ±â¼ú ¹ßÀüÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ÀÌ Áö¿ªÀº È®¸³µÈ °Ç°­ °ü¸® ÀÎÇÁ¶ó¿Í ³»½Ã°æ ÀýÂ÷ÀÇ °­È­¿¡ ÁÖ·ÂÇÏ´Â °ÍÀÌ ÀåÁ¡ÀÔ´Ï´Ù. ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú ÀÓ»óÀû È¿°ú´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ Áö¿ªÀÇ »óȲÀº Á¦Ç°ÀÇ ¼º´É°ú ¾ÈÀü¼º Çâ»ó¿¡ ÁßÁ¡À» µÐ Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å°ú ¿¬±¸¿¡ ÀÇÇØ Çü¼ºµË´Ï´Ù.

Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ ½ÃÀå : °æÀï ±¸µµ:

Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº Olympus, Medtronic, EndoClot Plus. µîÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÁÖ¿ä ±â¾÷µéÀº Á¡¸·À» µé¾î¿Ã·Á ³»½Ã°æ ¼ö¼úÀ» °³¼±ÇÏ°í º¸´Ù ³ªÀº ½Ã°¢È­¿Í Á¶ÀÛÀ» ½ÇÇöÇϵµ·Ï ¼³°èµÈ ÷´Ü Á¦Ç°À¸·Î ¾÷°è¸¦ ¼±µµÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå °³Ã´¿¡´Â »õ·Î¿î Á¦Á¦ ¹× Àü´Þ ½Ã½ºÅÛÀ» °³¹ßÇÏ´Â Çõ½ÅÀûÀÎ Áß¼Ò±â¾÷µµ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ßÀÇ ¼ºÀåÀ» Áö¿øÇÏ´Â °ÍÀº ³»½Ã°æ °Ë»çÀÇ ±â¼úÀû Áøº¸, ³·Àº ħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¾à¹°ÀÇ È¿´É°ú ¾ÈÀü¼ºÀ» ³ôÀ̱â À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ »ê¾÷ÀÇ Á¶»ç

Á¦5Àå Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ ½ÃÀå »óȲ

Á¦7Àå Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ ½ÃÀå : ¼ººÐº°

Á¦8Àå Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ ½ÃÀå : ¿ëµµº°

Á¦9Àå Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦10Àå Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ ½ÃÀå : Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - Á¡¸·ÇÏÃþ ¸®ÇÁÆÃÁ¦ ¾÷°è

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

BJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Submucosal Lifting Agent Market size was valued at USD 115.90 Million in 2023, expanding at a CAGR of 7.20% from 2024 to 2032.

A submucosal lifting agent is a medical substance used to elevate the mucosal layer during endoscopic procedures. Its primary application is in facilitating the removal of polyps, adenomas, and early-stage cancers by creating a cushion between the mucosa and underlying tissues. This lifting action allows for clearer visibility and easier manipulation of lesions, improving the precision and effectiveness of procedures like endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD). The agents are valued for their safety, efficacy, and ability to minimize complications during such interventions.

Submucosal Lifting Agent Market- Market Dynamics

The rising prevalence of gastrointestinal conditions, such as polyps, adenomas, and early-stage cancers

The increasing incidence of gastrointestinal disorders is a major factor driving the submucosal lifting agent market. For example, colorectal cancer, which often involves polyps and adenomas as precursors, is one of the most common cancers globally, with over 1.9 million new cases reported in 2020 alone. The prevalence of adenomatous polyps, which can progress to cancer if untreated, is significant, with studies indicating that up to 30% of adults over 50 may have these polyps. The rise in diagnoses has led to a greater need for precise endoscopic techniques, such as endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD), which rely on effective submucosal lifting agents. These agents help in creating a cushion between the mucosa and underlying tissues, enhancing the ability to remove and treat these lesions safely and effectively, thereby supporting the growing market for these products.

Submucosal Lifting Agent Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.20% over the forecast period (2024-2032)

Based on Ingredient segmentation, Sodium hyaluronate was predicted to show maximum market share in the year 2023

Based on Application segmentation Polyps was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Submucosal Lifting Agent Market- Segmentation Analysis:

The Global Submucosal Lifting Agent Market is segmented on the basis of Ingredient, Application, End USer, and Region.

The market is divided into six categories based on Ingredient: Sodium hyaluronate is often regarded as the most prominent ingredient in its class because of its exceptional ability to provide a stable submucosal lift. Its effectiveness is well-documented in clinical practice, where it is widely used due to its superior performance in mucosal lifting. Also, sodium hyaluronate is highly valued for its excellent biocompatibility, ensuring that it integrates seamlessly with the body's tissues, and its strong safety profile, which minimizes the risk of adverse reactions. This combination of efficacy, compatibility, and safety makes it a preferred choice in various medical and aesthetic applications.

The market is divided into five categories based on Application: Polyps often lead as the primary segment. This is because submucosal lifting is commonly employed in the removal and treatment of polyps, particularly in procedures like endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD). These techniques rely on the effective lifting of the mucosal layer to facilitate the precise removal of polyps and other lesions, making polyps a significant focus in this area.

Submucosal Lifting Agent Market- Geographical Insights

The North American market for submucosal lifting agents is characterized by strong demand for minimally invasive procedures and rapid technological advancements. The region benefits from a well-established healthcare infrastructure and a focus on enhancing endoscopic techniques. Regulatory approvals and clinical efficacy are critical factors driving market growth. The regional landscape is shaped by continuous innovation and research, with an emphasis on improving product performance and safety.

Submucosal Lifting Agent Market- Competitive Landscape:

Key players in the submucosal lifting agent market include Olympus, Medtronic, and EndoClot Plus. These companies lead the industry with advanced products designed to enhance endoscopic procedures by lifting the mucosal layer for better visualization and manipulation. The market also features contributions from smaller, innovative firms that are developing new formulations and delivery systems. Growth in this sector is supported by technological advancements in endoscopy, increasing demand for minimally invasive procedures, and ongoing research to enhance the effectiveness and safety of these agents.

Recent Developments:

In April 2023, Olympus announced the launch of EndoClot(R) Adhesive (ECA), EndoClot(R) Polysaccharide Hemostatic Spray (PHS), and EndoClot(R) Submucosal Injection Solution (SIS) across Europe, the Middle East, and Africa (EMEA).

In Sept 2022, Olympus Announces the U.S. Distribution of EndoClot Polysaccharide Hemostatic Spray and EndoClot Submucosal Injection Agent.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SUBMUCOSAL LIFTING AGENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL SUBMUCOSAL LIFTING AGENT MARKET, BY INGREDIENT- MARKET ANALYSIS, 2019 - 2032

GLOBAL SUBMUCOSAL LIFTING AGENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL SUBMUCOSAL LIFTING AGENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL SUBMUCOSAL LIFTING AGENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Submucosal Lifting Agent Market Overview

2. Executive Summary

3. Submucosal Lifting Agent Key Market Trends

4. Submucosal Lifting Agent Industry Study

5. Submucosal Lifting Agent Market: COVID-19 Impact Analysis

6. Submucosal Lifting Agent Market Landscape

7. Submucosal Lifting Agent Market - By Ingredient

8. Submucosal Lifting Agent Market - By Application

9. Submucosal Lifting Agent Market - By End User

10. Submucosal Lifting Agent Market- By Geography

11. Key Vendor Analysis- Submucosal Lifting Agent Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â